Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Aprea Therapeutics, Inc. (APRE) had Free Cash Flow per Share of $-2.46 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.50M |
|
$-12.96M |
|
-- |
|
$1.50M |
|
$15.82M |
|
$-14.32M |
|
$1.36M |
|
$-12.96M |
|
$-12.96M |
|
$-12.96M |
|
$-12.96M |
|
$-12.96M |
|
$-12.96M |
|
$-14.32M |
|
$-14.30M |
|
5.51M |
|
5.51M |
|
$-2.35 |
|
$-2.35 |
|
| Balance Sheet Financials | |
$23.58M |
|
$0.08M |
|
$0.40M |
|
$23.98M |
|
$3.36M |
|
-- |
|
$1.31M |
|
$4.67M |
|
$19.31M |
|
$19.31M |
|
$19.31M |
|
5.48M |
|
| Cash Flow Statement Financials | |
$-13.56M |
|
$-0.02M |
|
$14.82M |
|
$21.65M |
|
$22.89M |
|
$1.24M |
|
$0.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-953.00% |
|
-953.00% |
|
-951.52% |
|
-862.43% |
|
-862.43% |
|
$-13.57M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-67.12% |
|
-67.12% |
|
-54.04% |
|
-67.12% |
|
$3.52 |
|
|
Free Cash Flow per Share |
$-2.46 |
$-2.46 |
|